EUVIMEDEUVIMED entdecken
Crossref

Butyrate ameliorates lung inflammation in chronic obstructive pulmonary disease in association with the regulation of histone lactylation: A mechanistic study

Min Jiang, Qin Jiang, Haibo Wu, Xiaomei Duan, Fengbo Zhang, Haimei Ma, Fengsen Li, Jianbing Ding, Jing Wang, Xiumei Li

Life Sciences · 2026-02 · 386 · 124170

DOI: 10.1016/j.lfs.2025.124170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2026-02. Verfasst von Min Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Key Laboratory of Respiratory Disease Research, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830011, C…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Histones, Butyric Acid, Pneumonia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Xinjiang Uygur Autonomous Region Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study investigates the role and mechanism of butyrate in modulating lung inflammation in a murine model of chronic obstructive pulmonary disease (COPD). MATERIALS AND METHODS: A COPD mouse model was established via chronic cigarette smoke exposure and treated with sodium butyrate or a vehicle. Lung function, histopathology, gut microbiota, and SCFA (short-chain fatty acid) levels were assessed. RNA sequencing, chromatin immunoprecipitation sequencing, Western blot, immunofluorescence, and flow cytometry were employed to analyze transcriptomic changes, histone H3K18 lactylation (H3K18la), and immune cell infiltration. Human peripheral blood mononuclear cells from COPD patients and healthy controls were analyzed for H3K18la levels. KEY FINDINGS: Butyrate treatment improved lung function and ameliorated histopathological damage, which was associated with restored SCFA levels and altered gut microbiota. Transcriptomic analysis revealed butyrate downregulated genes in immune-inflammatory pathways (e.g., Th17 differentiation, MAPK) and upregulated metabolic genes. Moreover, butyrate treatment was accompanied by a suppression of global lactylation and H3K18la levels, manifested as reduced H3K18la enrichment on pro-inflammatory genes (e.g., in MAPK/JAK-STAT pathways) and increased enrichment on SOCS2. Butyrate reduced lung ILC2 cell numbers and inhibited H3K18la modification within remaining ILC2s. Clinically, H3K18la was significantly elevated in peripheral blood mononuclear cells from COPD patients. SIGNIFICANCE: Butyrate ameliorates COPD, an effect associated with the regulation of histone lactylation, leading to improved lung function and reduced inflammation. The findings highlight gut-derived metabolites' role in modulating epigenetic landscapes and offer potential therapeutic strategies for COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveHistonesButyric AcidPneumoniaButyratesAnimalsHumansMiceMaleMice, Inbred C57BLFemaleGastrointestinal MicrobiomeDisease Models, AnimalLeukocytes, MononuclearLung

Stichwörter der Autor:innen

ButyrateChronic obstructive pulmonary diseaseH3K18laILC2

Substanzen

HistonesButyric AcidButyrates

Autor:innen und Institutionen

  • Xinjiang Key Laboratory of Respiratory Disease Research, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830011, China.
  • School Hospital of Xinjiang Medical University, Urumqi, 830011, China.
  • Department of Clinical Laboratory, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
  • Department of Immunology, College of Basic Medicine, Xinjiang Medical University, Urumqi, 830017, China.
  • Xinjiang Key Laboratory of Respiratory Disease Research, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, Urumqi, 830011, China. Electronic address: jingw_xj@163.com.
  • Department of Morphology, College of Basic Medicine, Xinjiang Medical University, Urumqi, 830017, China. Electronic address: dr.lxm@xjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Xinjiang Uygur Autonomous Region Department of Science and Technology

Zitieren

APA

Jiang, M., Jiang, Q., Wu, H., Duan, X., Zhang, F., Ma, H., Li, F., Ding, J., Wang, J., & Li, X. (2026). Butyrate ameliorates lung inflammation in chronic obstructive pulmonary disease in association with the regulation of histone lactylation: A mechanistic study. Life Sciences, 386, 124170. https://doi.org/10.1016/j.lfs.2025.124170

Vancouver

Jiang M, Jiang Q, Wu H, Duan X, Zhang F, Ma H, et al. Butyrate ameliorates lung inflammation in chronic obstructive pulmonary disease in association with the regulation of histone lactylation: A mechanistic study. Life Sciences. 2026;386:124170. doi:10.1016/j.lfs.2025.124170

BibTeX
@article{Jiang2026,
  author = {Jiang, Min and Jiang, Qin and Wu, Haibo and Duan, Xiaomei and Zhang, Fengbo and Ma, Haimei and Li, Fengsen and Ding, Jianbing and Wang, Jing and Li, Xiumei},
  title = {Butyrate ameliorates lung inflammation in chronic obstructive pulmonary disease in association with the regulation of histone lactylation: A mechanistic study},
  journal = {Life Sciences},
  year = {2026},
  volume = {386},
  pages = {124170},
  doi = {10.1016/j.lfs.2025.124170}
}
Kostenlos starten →